Dive into SS-31 Explained: Unlock Youthful Energy at the Mito Level — a 6:45 deep-dive on SS-31 (Elamipretide), mitochondrial health, and the latest 2025 clinical updates. Dr. Ethan breaks down mechanisms, preclinical wins, human trials, safety, and real-world anti-aging potential for longevity seekers (35–65). Learn how SS-31 targets cardiolipin, reduces ROS, boosts ATP, and why FDA approval for Barth syndrome matters for mitochondrial medicine. Perfect for anyone curious about mitochondrial dysfunction, sarcopenia, HFpEF, AMD, and translational longevity science. Like and share if you found this useful. #SS31 #Elamipretide #Mitochondria #Longevity #AntiAging #BarthSyndrome #MitochondrialHealth

OUTLINE:

00:00:00 Opening and Episode Intro

00:01:32 Chapter 1 - Introducing SS-31

00:07:06 Chapter 2 - Mechanism

00:13:45 Chapter 3 - Preclinical Studies

00:21:14 Chapter 4 - Human Trials

00:26:31 Chapter 5 - Age-less Living Benefits

00:28:46 Chapter 6 - Safety

00:30:14 Chapter 7 - Future Outlook

00:31:13 Chapter 8 - Wrap Up